Product NDC: | 64455-106 |
Proprietary Name: | Venlafaxine hydrochloride |
Non Proprietary Name: | Venlafaxine hydrochloride |
Active Ingredient(s): | 37.5 mg/1 & nbsp; Venlafaxine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64455-106 |
Labeler Name: | BTA Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090071 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130101 |
Package NDC: | 64455-106-90 |
Package Description: | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64455-106-90) |
NDC Code | 64455-106-90 |
Proprietary Name | Venlafaxine hydrochloride |
Package Description | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64455-106-90) |
Product NDC | 64455-106 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Venlafaxine hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130101 |
Marketing Category Name | ANDA |
Labeler Name | BTA Pharmaceuticals |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 37.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |